BetterLife Pharma Inc. (BETRF)

Market Cap	7.66M -20.1%
Revenue (ttm)	n/a
Net Income	-1.32M
EPS	-0.01
Shares Out	161.79M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	24,056
Open	0.0485
Previous Close	0.0474
Day's Range	0.0485 - 0.0516
52-Week Range	0.0276 - 0.0879
Beta	0.54
RSI	48.43
Earnings Date	May 29, 2026

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to t...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: BETRF

Financial Performance

Financial numbers in CAD